Skip to content

Comparison of Glue Treatment and Laser Therapy for management of recurrent Varicose Veins

Assessment of Comparative Efficacy of Cyanoacrylate Glue vs Endovenous Laser Ablation for Recurrent Varicose Veins due to Residual / Recurrent Incompetent Perforators - RCT - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093813
Enrollment
200
Registered
2025-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I832- Varicose veins of lower extremities with both ulcer and inflammation

Interventions

Intervention1: Cyanoacrylate Gel Ablation: Patients with recurrent varicose veins attending our OPD during the study period considered for the study. Once the patients were diagnosed with recurrent va

Sponsors

Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to sign informed consent form and willing to participate in the study. 2. Patients diagnosed with varicose veins. 3. Patients with a clear history of prior treatment of the varicose veins. 4. Patients who have recurrent perforator as identified by ultrasound. 5. Patients belonging to C3 to C6 classes of the CEAP Classification.

Exclusion criteria

Exclusion criteria: 1. Patients with deep vein thrombosis. 2. Pregnant and lactating women. 3. Patients with immunocompromised status and terminal illness like cancer. 4. Patients with known allergy to cyanoacrylate adhesive. 5. Patients on treatment with anticoagulants or having any coagulopathy. 6. Patients not ready to consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
-To compare the closure rates of incompetent perforators at 6 month & 1 year post-procedure, as confirmed via Doppler ultrasound. - To assess improvement in clinical symptoms using the Venous Clinical Severity Score (VCSS) at 6 month and 1 year.Timepoint: 6 month and 1 year.

Secondary

MeasureTime frame
- To analyze the incidence of complications (immediate, at 6 month, and at 1 year) following each treatment modality. - To compare the average procedure time between n-butyl cyanoacrylate glue and endovenous laser ablation.Timepoint: Immediate, 6 month & 1 year

Countries

India

Contacts

Public ContactDr Lalit Kumar Nirwan

Datta Meghe Institute of Higher Education and Research (Deemed to be University)

drpjbanode@gmail.com9960713020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 16, 2026